Company filings profile · CIK 0001615219
Decoy Therapeutics Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Decoy Therapeutics Inc. (DCOY): 23 filings in the last 90 days vs 11 in the prior 90 (filing-velocity rising ↑ · 2.09×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 24, 2026. Source-linked, daily-refreshed.
Material 8-K events — Decoy Therapeutics Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 23, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 15, 2026 | Item 5.07 | ↗ |
| Jul 15, 2026 | Item 5.07 | ↗ |
| Jun 29, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 19, 2026 | Item 5.08; Other Events | ↗ |
| Apr 2, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Mar 5, 2026 | Item 3.03; Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Feb 25, 2026 | Item 5.07 | ↗ |
| Jan 8, 2026 | Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Jan 2, 2026 | Delisting / Listing-Rule Failure | ↗ |
Watch Decoy Therapeutics Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 23, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 15, 2026 | 8-K | Item 5.07 | ↗ |
| Sep 2, 2026 | 4 | 4 | ↗ |
| Sep 2, 2026 | 4 | 4 | ↗ |
| Sep 2, 2026 | 4 | 4 | ↗ |
| Sep 2, 2026 | 4 | 4 | ↗ |
| Sep 2, 2026 | 4 | 4 | ↗ |
| Sep 2, 2026 | 4 | 4 | ↗ |
| Sep 2, 2026 | 4 | 4 | ↗ |
| Sep 2, 2026 | 4 | 4 | ↗ |
| Sep 2, 2026 | 4 | 4 | ↗ |
| Sep 2, 2026 | 4 | 4 | ↗ |
| Aug 14, 2026 | SCHEDULE 13G | ↗ | |
| Aug 12, 2026 | 10-Q | 10-Q | ↗ |
| Aug 4, 2026 | DEF 14A | DEF 14A | ↗ |
| Aug 4, 2026 | DEFA14A | DEFA14A | ↗ |
| Jul 31, 2026 | 3 | 3 | ↗ |
| Jul 24, 2026 | PRE 14A | PRE 14A | ↗ |
| Jul 17, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jul 17, 2026 | 424B3 | 424B3 | ↗ |
| Jul 15, 2026 | 8-K | Item 5.07 | ↗ |
| Jul 10, 2026 | S-1 | S-1 | ↗ |
| Jun 29, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 24, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jun 15, 2026 | S-1 | S-1 | ↗ |
| Jun 5, 2026 | RW | RW | ↗ |
| Jun 4, 2026 | DEFA14A | DEFA14A | ↗ |
| Jun 4, 2026 | DEF 14A | DEF 14A | ↗ |
| May 19, 2026 | 8-K | Item 5.08; Other Events | ↗ |
| May 8, 2026 | 10-Q | 10-Q | ↗ |
| Apr 30, 2026 | 10-K/A | 10-K/A | ↗ |
| Apr 2, 2026 | S-8 | S-8 | ↗ |
| Apr 2, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Mar 31, 2026 | 10-K | 10-K | ↗ |
| Mar 5, 2026 | 8-K | Item 3.03; Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Feb 25, 2026 | 8-K | Item 5.07 | ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Jan 9, 2026 | DEF 14A | DEF 14A | ↗ |
| Jan 8, 2026 | 8-K | Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Jan 2, 2026 | 8-K | Delisting / Listing-Rule Failure | ↗ |